FDA staff: Gilead’s Truvada might assistance forestall HIV infection

<p>WASHINGTON (Reuters) – <span>Gilead Sciences Inc</span>‘s Truvada might forestall <span>HIV infection</span> among high-risk individuals, if used in multiple with other <span>health strategies</span>, and is well-tolerated by people who have not engaged a pathogen that causes AIDS, <span>U.S. Food and Drug Administration review</span> papers pronounced on Tuesday.</p>
<p> (Reporting By <span>David Morgan</span>, modifying by <span>Dave Zimmerman</span>)</p>
<p><img src="http://imageads.googleadservices.com/pagead/ads?format=468x30_aff_img&client=&channel=&output=png&cuid=2022&url=%20http%3A%2F%2Fmedicalinfo.info%2F%3Fp%3D2022" alt="ads?format=468x30_aff_img&client=&channe" /></p>...